GLP-1 Use and Fatigue
ChatGPTMay 26, 2025 Fatigue or low energy is a commonly reported side effect among users of GLP-1 receptor agonists like semaglutide (Ozempic/Wegovy) or tirzepatide (Mounjaro/Zepbound), but it is not as well characterized or studied as gastrointestinal effects. Here’s what is currently known: 🔍 What We Know About Fatigue and GLP-1 Use ✅ PrevalenceFatigue is reported […]
Study compares Zepbound and Wegovy for weight loss in direct comparison
Weight-loss medications continue to grow in popularity as an anti-obesity tool — but are some more effective than others? The question was explored in a new study published this month in The New England Journal of Medicine. Researchers compared the safety and efficacy of tirzepatide (brand name Zepbound) and semaglutide (brand name Wegovy) in a […]
Ozempic teeth, face and tongue: Side effects of GLP-1 drugs explained
As the use of weight-loss injections rises, users report effects like Ozempic face, tongue, and teeth- here is what these mean and how to manage them
Why Ozempic could be the answer to ageing (and it’s not about weight loss)
For future generations, it’s quite plausible that their most important 50th birthday present will be an Ozempic prescription from their GP, designed to slow down the ageing process and prolong their years of good health. That’s the provocative suggestion of Gaetano Santulli, Associate Professor at the Albert Einstein College of Medicine in New York, one […]
Cigna debuts GLP-1 copay cap
Cigna subsidiary Evernorth Health Services will automate prior authorizations for GLP-1 weight-loss drugs under a new program
Scientists Discover Powerful Anti-Cancer Benefits of Popular Weight Loss Drugs
After adjusting for the weight loss benefits of surgery, GLP-1 drugs were linked to a 41% lower risk of obesity-related cancer. New research presented at the European Congress on Obesity (ECO) in Malaga, Spain, and published in the journal eClinicalMedicine, suggests that some widely used weight-loss medications may do more than just help people slim […]
New Data on GLP-1 RAs and Psychiatric Side Effects
New review confirms psychiatric safety of commonly used glucagon-like peptide 1 receptor agonists among patients without preexisting mental illness. Medscape Medical News
What are GLP-1 medications?
GLP-1s are drugs that help people manage diabetes and lose weight. Their surging popularity has a range of economic and public health implications.